Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 09-Sep-24 5:30 PM View:  | Michaelson Jennifer Chief Scientific Officer | Cullinan Therapeutics, Inc. (CGEM) | 05-Sep-24 | Private Sale (Planned) | 8,000 | $18.09 | $144,720.00 | (6%) 123.94K to 115.94K | |
| 09-Jul-24 5:30 PM View: | Michaelson Jennifer Chief Scientific Officer | Cullinan Therapeutics, Inc. (CGEM) | 05-Jul-24 | Private Sale (Planned) | 8,000 | $16.33 | $130,640.00 | (6%) 131.94K to 123.94K | |
| 02-Jul-24 7:30 PM View: | Michaelson Jennifer Chief Scientific Officer | Cullinan Therapeutics, Inc. (CGEM) | 01-Jul-24 | Grant | 2,360 | $9.00 | $21,240.00 | 2% 129.58K to 131.94K | |
| 11-Jun-24 6:00 PM View: | Ebeling Thomas Director | Cullinan Therapeutics, Inc. (CGEM) | 10-Jun-24 | Option Exercise | 18,450 | $13.00 | $239,850.00 | 11% 168.2K to 186.65K | |
| 23-May-24 4:11 PM View: | Ebeling Thomas Director | Cullinan Therapeutics, Inc. (CGEM) | 23-May-24 | Grant | 100,699 | $5.68 | $571,890.00 | 149% 67.5K to 168.2K | |
| 08-May-24 7:30 PM View: | Michaelson Jennifer Chief Scientific Officer | Cullinan Therapeutics, Inc. (CGEM) | 07-May-24 | Option Exercise | 5,606 | $4.30 | $24,105.80 | 4% 129.58K to 135.19K | |
| 08-May-24 7:30 PM View: | Michaelson Jennifer Chief Scientific Officer | Cullinan Therapeutics, Inc. (CGEM) | 07-May-24 | Sale (Planned) | 5,606 | $30.06 | $168,516.00 | (4%) 135.19K to 129.58K | |
| 08-May-24 7:30 PM View: | Michaelson Jennifer Chief Scientific Officer | Cullinan Therapeutics, Inc. (CGEM) | 06-May-24 | Planned Option Sale | 55,606 | $28.07 | $1,560,960.00 | (30%) 187.58K to 131.98K | |
| 08-May-24 7:30 PM View: | Michaelson Jennifer Chief Scientific Officer | Cullinan Therapeutics, Inc. (CGEM) | 06-May-24 | Option Exercise | 50,000 | $4.30 | $215,000.00 | 36% 137.58K to 187.58K | |
| 08-May-24 7:30 PM View: | Michaelson Jennifer Chief Scientific Officer | Cullinan Therapeutics, Inc. (CGEM) | 06-May-24 | Sale (Planned) | 2,394 | $28.07 | $67,203.70 | (2%) 131.98K to 129.58K | |
| 23-Feb-24 5:00 PM View: | Savill Corrine Chief Business Officer | Cullinan Therapeutics, Inc. (CGEM) | 22-Feb-24 | Grant | 37,500 | -- | -- | 23% 165.99K to 203.49K | |
| 23-Feb-24 5:00 PM View: | Jones Jeffrey Alan Chief Medical Officer | Cullinan Therapeutics, Inc. (CGEM) | 22-Feb-24 | Grant | 62,500 | -- | -- | 111% 56.19K to 118.69K | |
| 23-Feb-24 5:00 PM View: | Ahmed Nadim President and CEO Director | Cullinan Therapeutics, Inc. (CGEM) | 22-Feb-24 | Grant | 160,000 | -- | -- | 143% 111.55K to 271.55K | |
| 23-Feb-24 5:00 PM View: | Michaelson Jennifer Chief Scientific Officer | Cullinan Therapeutics, Inc. (CGEM) | 22-Feb-24 | Grant | 50,000 | -- | -- | 57% 87.58K to 137.58K | |
| 23-Feb-24 5:00 PM View: | Trigilio Jeffrey Chief Financial Officer | Cullinan Therapeutics, Inc. (CGEM) | 22-Feb-24 | Grant | 50,000 | -- | -- | 60% 83.92K to 133.92K | |
| 23-Feb-24 5:00 PM View: | Sumer Jacquelyn L Chief Legal Officer | Cullinan Therapeutics, Inc. (CGEM) | 22-Feb-24 | Grant | 50,000 | -- | -- | 113% 44.13K to 94.13K | |
| 02-Feb-24 9:35 PM View: | Savill Corrine Chief Business Officer | Cullinan Therapeutics, Inc. (CGEM) | 01-Feb-24 | Planned Option Sale | 40,000 | $16.18 | $647,200.00 | (19%) 205.99K to 165.99K | |
| 02-Feb-24 9:35 PM View: | Savill Corrine Chief Business Officer | Cullinan Therapeutics, Inc. (CGEM) | 01-Feb-24 | Option Exercise | 40,000 | $4.30 | $172,000.00 | 24% 165.99K to 205.99K | |
| 30-Jan-24 7:00 PM View: | Savill Corrine Chief Business Officer | Cullinan Therapeutics, Inc. (CGEM) | 29-Jan-24 | Option Exercise | 40,000 | $4.30 | $172,000.00 | 24% 165.99K to 205.99K | |
| 30-Jan-24 7:00 PM View: | Savill Corrine Chief Business Officer | Cullinan Therapeutics, Inc. (CGEM) | 29-Jan-24 | Planned Option Sale | 40,000 | $14.09 | $563,600.00 | (19%) 205.99K to 165.99K | |
| 24-Jan-24 5:00 PM View: | Savill Corrine Chief Business Officer | Cullinan Therapeutics, Inc. (CGEM) | 23-Jan-24 | Planned Option Sale | 17,191 | $12.46 | $214,200.00 | (9%) 187.31K to 170.12K | |
| 24-Jan-24 5:00 PM View: | Savill Corrine Chief Business Officer | Cullinan Therapeutics, Inc. (CGEM) | 23-Jan-24 | Sale (Planned) | 4,125 | $12.46 | $51,397.50 | (2%) 170.12K to 165.99K | |
| 24-Jan-24 5:00 PM View: | Savill Corrine Chief Business Officer | Cullinan Therapeutics, Inc. (CGEM) | 23-Jan-24 | Option Exercise | 21,316 | $4.30 | $91,658.80 | 13% 165.99K to 187.31K | |
| 24-Jan-24 5:00 PM View: | Savill Corrine Chief Business Officer | Cullinan Therapeutics, Inc. (CGEM) | 22-Jan-24 | Option Exercise | 14,559 | $4.30 | $62,603.70 | 9% 170.12K to 184.67K | |
| 24-Jan-24 5:00 PM View: | Savill Corrine Chief Business Officer | Cullinan Therapeutics, Inc. (CGEM) | 22-Jan-24 | Planned Option Sale | 18,684 | $12.14 | $226,911.00 | (10%) 184.67K to 165.99K | |
| 27-Dec-23 6:30 PM View: | Ahmed Nadim President and CEO Director | Cullinan Therapeutics, Inc. (CGEM) | 26-Dec-23 | Sale | 4,272 | $9.24 | $39,473.30 | (4%) 115.82K to 111.55K | |
| 22-Dec-23 5:30 PM View: | Jones Jeffrey Alan Chief Medical Officer | Cullinan Therapeutics, Inc. (CGEM) | 21-Dec-23 | Sale | 1,860 | $8.50 | $15,810.00 | (3%) 58.05K to 56.19K | |
| 22-Dec-23 5:30 PM View: | Michaelson Jennifer Chief Scientific Officer | Cullinan Therapeutics, Inc. (CGEM) | 21-Dec-23 | Sale | 1,145 | $8.50 | $9,732.50 | (1%) 88.73K to 87.58K | |
| 22-Dec-23 5:30 PM View: | Sumer Jacquelyn L Chief Legal Officer | Cullinan Therapeutics, Inc. (CGEM) | 21-Dec-23 | Sale | 1,400 | $8.50 | $11,900.00 | (3%) 45.53K to 44.13K | |
| 22-Dec-23 5:30 PM View: | Trigilio Jeffrey Chief Financial Officer | Cullinan Therapeutics, Inc. (CGEM) | 21-Dec-23 | Sale | 1,920 | $8.50 | $16,320.00 | (2%) 85.84K to 83.92K | |
| 20-Dec-23 6:00 PM View: | Sumer Jacquelyn L Chief Legal Officer | Cullinan Therapeutics, Inc. (CGEM) | 18-Dec-23 | Sale | 290 | $8.22 | $2,383.80 | (< 1%) 45.82K to 45.53K | |
| 20-Dec-23 6:00 PM View: | Trigilio Jeffrey Chief Financial Officer | Cullinan Therapeutics, Inc. (CGEM) | 18-Dec-23 | Sale | 398 | $8.22 | $3,271.56 | (< 1%) 86.24K to 85.84K | |
| 20-Dec-23 6:00 PM View: | Jones Jeffrey Alan Chief Medical Officer | Cullinan Therapeutics, Inc. (CGEM) | 18-Dec-23 | Sale | 386 | $8.22 | $3,172.92 | (< 1%) 58.44K to 58.05K | |
| 20-Dec-23 6:00 PM View: | Michaelson Jennifer Chief Scientific Officer | Cullinan Therapeutics, Inc. (CGEM) | 18-Dec-23 | Sale | 238 | $8.22 | $1,956.36 | (< 1%) 88.97K to 88.73K | |
| 13-Dec-23 8:00 PM View: | Trigilio Jeffrey Chief Financial Officer | Cullinan Therapeutics, Inc. (CGEM) | 12-Dec-23 | Sale | 1,926 | $7.81 | $15,042.10 | (2%) 88.16K to 86.24K | |
| 13-Dec-23 8:00 PM View: | Michaelson Jennifer Chief Scientific Officer | Cullinan Therapeutics, Inc. (CGEM) | 12-Dec-23 | Sale | 1,068 | $7.81 | $8,341.08 | (1%) 90.03K to 88.97K | |
| 29-Jun-23 4:59 PM View: | Ahmed Nadim President and CEO Director | Cullinan Therapeutics, Inc. (CGEM) | 28-Jun-23 | Sale | 759 | $11.40 | $8,652.60 | (< 1%) 116.58K to 115.82K | |
| 21-Jun-23 4:17 PM View: | Jones Jeffrey Alan Chief Medical Officer | Cullinan Therapeutics, Inc. (CGEM) | 20-Jun-23 | Market Sale | 387 | $12.94 | $5,007.78 | (< 1%) 58.82K to 58.44K | (13%) |
| 21-Jun-23 4:17 PM View: | Michaelson Jennifer Chief Development Officer | Cullinan Therapeutics, Inc. (CGEM) | 20-Jun-23 | Market Sale | 238 | $12.94 | $3,079.72 | (< 1%) 90.27K to 90.03K | (13%) |
| 21-Jun-23 4:17 PM View: | Trigilio Jeffrey Chief Financial Officer | Cullinan Therapeutics, Inc. (CGEM) | 20-Jun-23 | Market Sale | 399 | $12.94 | $5,163.06 | (< 1%) 86.22K to 85.82K | (13%) |
| 21-Jun-23 4:17 PM View: | Sumer Jacquelyn L Chief Legal Officer | Cullinan Therapeutics, Inc. (CGEM) | 20-Jun-23 | Market Sale | 291 | $12.94 | $3,765.54 | (< 1%) 46.11K to 45.82K | (13%) |
| 14-Jun-23 4:35 PM View: | Trigilio Jeffrey Chief Financial Officer | Cullinan Therapeutics, Inc. (CGEM) | 12-Jun-23 | Market Sale | 319 | $13.11 | $4,182.09 | (< 1%) 86.54K to 86.22K | (12%) |
| 14-Jun-23 4:35 PM View: | Michaelson Jennifer Chief Development Officer | Cullinan Therapeutics, Inc. (CGEM) | 12-Jun-23 | Market Sale | 176 | $13.11 | $2,307.36 | (< 1%) 90.45K to 90.27K | (12%) |
| 08-Jun-23 5:10 PM View: | Michaelson Jennifer Chief Development Officer | Cullinan Therapeutics, Inc. (CGEM) | 07-Jun-23 | Option Exercise | 100 | $4.30 | $430.00 | < 1% 90.45K to 90.55K | |
| 08-Jun-23 5:10 PM View: | Michaelson Jennifer Chief Development Officer | Cullinan Therapeutics, Inc. (CGEM) | 07-Jun-23 | Planned Option Sale | 100 | $12.40 | $1,240.00 | (< 1%) 90.55K to 90.45K | |
| 08-Jun-23 5:10 PM View: | Michaelson Jennifer Chief Development Officer | Cullinan Therapeutics, Inc. (CGEM) | 06-Jun-23 | Planned Option Sale | 11,900 | $12.31 | $146,489.00 | (12%) 102.35K to 90.45K | |
| 08-Jun-23 5:10 PM View: | Michaelson Jennifer Chief Development Officer | Cullinan Therapeutics, Inc. (CGEM) | 06-Jun-23 | Option Exercise | 11,900 | $4.30 | $51,170.00 | 13% 90.45K to 102.35K | |
| 24-May-23 4:36 PM View: | Ahmed Nadim President and CEO Director | Cullinan Therapeutics, Inc. (CGEM) | 23-May-23 | Sale | 707 | $9.15 | $6,469.05 | (< 1%) 117.29K to 116.58K | |
| 19-May-23 4:45 PM View: | Sumer Jacquelyn L Chief Legal Officer | Cullinan Therapeutics, Inc. (CGEM) | 18-May-23 | Sale | 291 | $8.76 | $2,549.16 | (< 1%) 46.41K to 46.11K | |
| 19-May-23 4:44 PM View: | Trigilio Jeffrey Chief Financial Officer | Cullinan Therapeutics, Inc. (CGEM) | 18-May-23 | Sale | 399 | $8.76 | $3,495.24 | (< 1%) 86.94K to 86.54K |
